Systemic Ketone Replacement Does Not Improve Survival or Cancer Cachexia in Mice With Lung Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Henning Tim,Langer ^[1] ; Shakti,Ramsamooj ^[2] ; Roger J,Liang ^[1] ; Rahul,Grover ^[2] ; Seo-Kyoung,Hwang ^[1] ; Marcus DaSilva,Goncalves ^[2]

作者单位： Division of Endocrinology, Weill Department of Medicine, Weill Cornell Medicine, New York, NY, United States. ^[1] Meyer Cancer Center, Weill Department of Medicine, Weill Cornell Medicine, New York, NY, United States. ^[2]

关键词 PPAR alpha beta hydroxybutyrate cachexia ketogenic diet (KD)ketone ester supplementation lung cancer

DOI 10.3389/fonc.2022.903157

PMID 35719965

发布时间 2022-08-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

903157页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Systemic Ketone Replacement Does Not Improve Survival or Cancer Cachexia in Mice With Lung Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Systemic Ketone Replacement Does Not Improve Survival or Cancer Cachexia in Mice With Lung Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除